Li-Jen Cheng

2PUBLICATIONS
3CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 17, 2021
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore.

Li-Jen Cheng, Lydia Loke, Elaine Hsuen Lim

Pageof 1